LA Foot and Ankle
Welcome,         Profile    Billing    Logout  
 5 Trials 
21 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sigal, Felix
NCT06140303: SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Recruiting
3
100
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Professional Education and Research Institute
Diabetic Foot
12/25
03/26
NCT06267560: Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Recruiting
3
400
US
TQJ230, pelacarsen, Placebo
Novartis Pharmaceuticals
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
03/27
03/27
COVER DFUs, NCT05372809: Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

Terminated
3
42
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Alira Health
Diabetic Foot
02/24
02/24
PL-5, NCT06189638: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide in Mild Infections of Diabetic Foot Ulcers

Active, not recruiting
2
90
US
Antimicrobial Peptide PL-5 Topical Spray and Placebo, AMP PL-5 and Placebo
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., Parexel
Diabetic Foot Ulcers
04/27
12/27
NCT05588583: A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Recruiting
N/A
68
US
Mepilex Up
Molnlycke Health Care AB
Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer
03/24
03/24
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Suspended
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/25
01/26
NCT06453187: A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Recruiting
N/A
350
US
Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers, Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers, AmnioExcel Plus for Venous Leg Ulcers, AmnioExcel Plus for Diabetic Foot Ulcers, Standard of Care
Integra LifeSciences Corporation, SerenaGroup, Inc.
Diabetic Foot Ulcer, Venous Leg Ulcer
06/26
08/26
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25
IDEAL, NCT06616844: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Recruiting
N/A
194
US
InnovaMatrix® AC, Porcine Placental ExtraCellular Matrix (PPECM)
ConvaTec Inc.
Wound Heal, Ulcer
02/26
07/26
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Recruiting
N/A
450
US
COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device
Piomic Medical, NAMSA
Diabetic Foot Ulcer
06/27
06/27
Jackson, Maira
NCT06140303: SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Recruiting
3
100
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Professional Education and Research Institute
Diabetic Foot
12/25
03/26
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

Recruiting
2
288
US
CIN-102 Dose 15mg or 10mg, Placebo
CinDome Pharma, Inc.
Diabetic Gastroparesis
09/25
09/25
BGWM, NCT06403605: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Recruiting
N/A
100
US
Mirragen Wound Matrix, Fibracol
ETS Wound Care, LLC, Professional Education and Research Institute
Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
12/24
12/24
NCT05588583: A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Recruiting
N/A
68
US
Mepilex Up
Molnlycke Health Care AB
Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer
03/24
03/24
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Suspended
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/25
01/26
NCT06453187: A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Recruiting
N/A
350
US
Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers, Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers, AmnioExcel Plus for Venous Leg Ulcers, AmnioExcel Plus for Diabetic Foot Ulcers, Standard of Care
Integra LifeSciences Corporation, SerenaGroup, Inc.
Diabetic Foot Ulcer, Venous Leg Ulcer
06/26
08/26
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25
IDEAL, NCT06616844: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Recruiting
N/A
194
US
InnovaMatrix® AC, Porcine Placental ExtraCellular Matrix (PPECM)
ConvaTec Inc.
Wound Heal, Ulcer
02/26
07/26
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Recruiting
N/A
450
US
COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device
Piomic Medical, NAMSA
Diabetic Foot Ulcer
06/27
06/27
Mathis, Stanley
PL-5, NCT06189638: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide in Mild Infections of Diabetic Foot Ulcers

Active, not recruiting
2
90
US
Antimicrobial Peptide PL-5 Topical Spray and Placebo, AMP PL-5 and Placebo
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., Parexel
Diabetic Foot Ulcers
04/27
12/27
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sigal, Felix
NCT06140303: SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Recruiting
3
100
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Professional Education and Research Institute
Diabetic Foot
12/25
03/26
NCT06267560: Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Recruiting
3
400
US
TQJ230, pelacarsen, Placebo
Novartis Pharmaceuticals
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
03/27
03/27
COVER DFUs, NCT05372809: Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

Terminated
3
42
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Alira Health
Diabetic Foot
02/24
02/24
PL-5, NCT06189638: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide in Mild Infections of Diabetic Foot Ulcers

Active, not recruiting
2
90
US
Antimicrobial Peptide PL-5 Topical Spray and Placebo, AMP PL-5 and Placebo
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., Parexel
Diabetic Foot Ulcers
04/27
12/27
NCT05588583: A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Recruiting
N/A
68
US
Mepilex Up
Molnlycke Health Care AB
Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer
03/24
03/24
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Suspended
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/25
01/26
NCT06453187: A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Recruiting
N/A
350
US
Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers, Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers, AmnioExcel Plus for Venous Leg Ulcers, AmnioExcel Plus for Diabetic Foot Ulcers, Standard of Care
Integra LifeSciences Corporation, SerenaGroup, Inc.
Diabetic Foot Ulcer, Venous Leg Ulcer
06/26
08/26
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25
IDEAL, NCT06616844: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Recruiting
N/A
194
US
InnovaMatrix® AC, Porcine Placental ExtraCellular Matrix (PPECM)
ConvaTec Inc.
Wound Heal, Ulcer
02/26
07/26
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Recruiting
N/A
450
US
COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device
Piomic Medical, NAMSA
Diabetic Foot Ulcer
06/27
06/27
Jackson, Maira
NCT06140303: SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Recruiting
3
100
US
SkinTE, Autologous Heterogeneous Skin Construct, Control, Standard of Care
PolarityTE, Professional Education and Research Institute
Diabetic Foot
12/25
03/26
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

Recruiting
2
288
US
CIN-102 Dose 15mg or 10mg, Placebo
CinDome Pharma, Inc.
Diabetic Gastroparesis
09/25
09/25
BGWM, NCT06403605: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Recruiting
N/A
100
US
Mirragen Wound Matrix, Fibracol
ETS Wound Care, LLC, Professional Education and Research Institute
Diabetic Foot Ulcer, Ulcer Foot, Diabetic Foot
12/24
12/24
NCT05588583: A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Recruiting
N/A
68
US
Mepilex Up
Molnlycke Health Care AB
Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer
03/24
03/24
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Suspended
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/25
01/26
NCT06453187: A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Recruiting
N/A
350
US
Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers, Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers, AmnioExcel Plus for Venous Leg Ulcers, AmnioExcel Plus for Diabetic Foot Ulcers, Standard of Care
Integra LifeSciences Corporation, SerenaGroup, Inc.
Diabetic Foot Ulcer, Venous Leg Ulcer
06/26
08/26
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25
IDEAL, NCT06616844: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Recruiting
N/A
194
US
InnovaMatrix® AC, Porcine Placental ExtraCellular Matrix (PPECM)
ConvaTec Inc.
Wound Heal, Ulcer
02/26
07/26
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Recruiting
N/A
450
US
COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device
Piomic Medical, NAMSA
Diabetic Foot Ulcer
06/27
06/27
Mathis, Stanley
PL-5, NCT06189638: Phase II Study to Evaluate Efficacy and Safety of AMP Peptide in Mild Infections of Diabetic Foot Ulcers

Active, not recruiting
2
90
US
Antimicrobial Peptide PL-5 Topical Spray and Placebo, AMP PL-5 and Placebo
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd., Parexel
Diabetic Foot Ulcers
04/27
12/27
NCT06035536: Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Recruiting
N/A
120
US
Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol
Aroa Biosurgery Limited, Professional Education and Research Institute
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
12/25
12/25

Download Options